Charles River Laboratories International Inc.

NYSE:CRL   3:59:59 PM EDT
-6.56 (-2.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)15.71B
Current PE38.96
Forward PE 30.34
2yr Forward PE 26.79
See more stats
Estimates Current Quarter
Revenue$888.31 Million
Adjusted EPS$2.43
See more estimates
10-Day MA$330.85
50-Day MA$359.08
200-Day MA$379.12
See more pivots

Charles River Laboratories International Inc. Stock, NYSE:CRL

251 Ballardvale Street, Wilmington, Massachusetts 01887
Phone: +1.781.222.6000
Number of Employees: 18400


Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support. The Research Models & Services segment consists of the production and sale of research models, and offers services designed to support its clientsâ?? use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it includes both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.